Prosperity Capital Advisors’s Bristol-Myers Squibb BMY Stock Holding History

Prosperity Capital Advisors’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-4,106	Closed	-$249K	–	426
2026 Q1	$249K	Sell	4,106 -80	-2%	-$4.66K	0.01%	361
2025 Q4	$226K	Sell	4,186 -830	-17%	-$39.9K	0.01%	357
2025 Q3	$226K	Sell	5,016 -1,287	-20%	-$60.1K	0.01%	391
2025 Q2	$292K	Sell	6,303 -513	-8%	-$25.2K	0.02%	329
2025 Q1	$406K	Buy	+6,816	New	+$397K	0.03%	255
2024 Q2	–	Sell	-4,431	Closed	-$240K	–	317
2024 Q1	$240K	Buy	+4,431	New	+$226K	0.03%	294

Other funds holding BMY

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

AIM

Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

FWIA

Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

DLA

Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

ETC

Exchange Traded Concepts Oklahoma City, Oklahoma $21.9B AUM 68.6% 1-Year Est. Return

Prosperity Capital Advisors's BMY Position: Q2 2026 in Review

Prosperity Capital Advisors sold out of Bristol-Myers Squibb (BMY) in Q2 2026, closing a stake of 4,106 shares — an estimated $249K sold.

Prosperity Capital Advisors first reported a position in BMY in Q1 2024 and held it in 6 quarters. The position peaked at $406K in Q1 2025. 831 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

Prosperity Capital Advisors reported no remaining Bristol-Myers Squibb position as of Q2 2026 after selling out during the quarter.
Prosperity Capital Advisors sold 4,106 Bristol-Myers Squibb shares in Q2 2026, an estimated $249K.
Prosperity Capital Advisors first reported a position in Bristol-Myers Squibb in Q1 2024 and held it in 6 quarters.
Prosperity Capital Advisors's Bristol-Myers Squibb position peaked at $406K in Q1 2025.
831 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Prosperity Capital Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.